Information on the implemented tax strategy for 2023

Sep 18, 2025 1 min read
Information on the implemented tax strategy for 2023

Informacja o realizowanej strategii podatkowej za 2023 rok

Polpharma Biologics S.A. jest zobowiązana do sporządzenia i opublikowania informacji o realizowanej strategii podatkowej w celu wykonania obowiązku określonego w art. 27c ust. 1 w związku z art. 27b ust. 2 pkt 1 i 2 Ustawy z dnia 15 lutego 1992 r. o podatku dochodowym od osób prawnych. Zapraszamy do zapoznania się z dokumentem.

Information on the implemented tax strategy for 2023

Polpharma Biologics S.A. is required to prepare and publish information on the executed tax strategy in order to fulfill the obligation set forth in Article 27c paragraph 1 in connection with Article 27b paragraph 2 points 1 and 2 of the Corporate Income Tax Act of February 15, 1992. We invite you to read the document.

Share this:
Blog posts

Read more

Thumbnail image of the post with the title: Rezon Bio Appoints Dr. Hubert Scholze as Chief Business Officer to Accelerate Global Commercial Expansion  Press Release

Rezon Bio Appoints Dr. Hubert Scholze as Chief Business Officer to Accelerate Global Commercial Expansion 

Jul 1, 2026
Ready to get started?

Where innovation meets execution

  1. Whether you’re advancing a novel biologic or planning for commercial scale, Rezon Bio is ready to help you move forward with confidence.
  2. Connect with our team to explore how our expertise, integrated solutions, and dedication can accelerate your success.